TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
BWAY

Brainsway Ltd

Healthcare · Medical Devices

13.30$ -0.5% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Brainsway Ltd (BWAY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 57.8% of the shares are freely tradable; institutional investors hold 29.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 29.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 6.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 57.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 40Mio.

Largest Shareholders

Institutions

Institutions BWAY
Name Stake (%) Shares Change (%) Date
Valor Management LLC 13.22 5,314,950 +0.0 06/30/2026
Masters Capital Management LLC 3.73 1,500,000 -9.1 06/30/2026
Acadian Asset Management LLC 2.04 818,272 +0.0 03/31/2026
Essex Investment Management Company, LLC 1.47 592,606 -4.2 06/30/2026
Renaissance Technologies Corp 1.29 518,420 -6.4 03/31/2026
Cresset Asset Management, LLC 0.78 314,924 +0.0 03/31/2026
Y.D. More Investments Ltd 0.68 272,004 +18.3 03/31/2026
SEI Investments Co 0.56 226,378 +81.2 03/31/2026
Legato Capital Management LLC 0.49 197,635 +2.9 06/30/2026
ARK Investment Management LLC 0.48 193,686 -23.9 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?